Exegenesis Bio Alternatives & Competitors
12 companies similar to Exegenesis Bio — We are reimagining ways to develop & manufacture gene therapies. Our mission is...
Companies similar to Exegenesis Bio
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Spur Therapeutics
Toward the next generation of gene therapy.
Stevenage, United Kingdom
Replay
Reprogramming biology by writing and delivering big DNA
San Diego, United States
Rival Readout
Competing with Exegenesis Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Lexeo Therapeutics
Advancing science with curative potential for both cardiovascular and APOE4 associated Alz...
New York, United States
AskBio Inc.
Pioneering science to create transformative molecular medicines.
United States
Apertura Gene Therapy
Bringing the Future of Gene Therapy into Focus
New York, United States
Hummingbird Bioscience
Hummingbird Bioscience is a biotherapeutics company working at the interface of AI and hum...
Singapore, Singapore
Clarametyx Biosciences
Targeting biofilms to treat chronic respiratory disease
Columbus, United States
Modalis Therapeutics
Modalis is an emerging biotech company that develops therapeutics using CRISPR based techn...
Cambridge, United States
Compugen
A clinical-stage cancer immunotherapy company and a pioneer in computational target discov...
Israel
Denmark
About Exegenesis Bio
Exegenesis Bio is a pioneering clinical stage global gene therapy company, founded in 2019, with operations in Philadelphia, Boston, and China. Their mission is encapsulated in their slogan: "We are reimagining ways to develop & manufacture gene therapies. Our mission is to improve efficacy, safety & access." The compa...
gene therapy solutions, biomedical research, therapeutics development, clinical trial management
healthcare providers, pharmaceutical companies, research institutions, biotech investors
Gene Therapy, AAV Gene Therapy, Neurovascular AMD Therapy, Spinal Muscular Atrophy Therapy, Biotech Manufacturing, Proprietary Capsids, Protein Engineering, CGMP Facilities, Clinical Stage Pipeline, Disposable Bioreactors, Plasmid Fermenters, Liver-directed Diseases, CNS Diseases, Eye Disease Therapies, Hemophilia Treatments
B2B
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Exegenesis Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Exegenesis Bio on 3 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
